Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease

Department of Pediatrics, University Hospitals of Geneva, Geneva, Switzerland.
Journal of pediatric gastroenterology and nutrition (Impact Factor: 2.63). 01/2012; 54(6):817-9. DOI: 10.1097/MPG.0b013e318248e7be
Source: PubMed


Patients with celiac disease have an increased risk for severe influenza infection and they show less of a response to certain vaccine types. During the influenza A/H1N1/09 pandemic, we prospectively investigated pandemic vaccine responses in 14 pediatric patients with celiac disease and age-/sex-matched controls. All of the children with celiac disease reached protective antibody titers (≥40) and showed a geometric mean titer comparable with the control group (530 vs 573).

Download full-text


Available from: Michela G Schäppi,